This inventor holds 1 USPTO granted patent. Top assignee: Message Pharmaceuticals, Inc.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: The Innovative Contributions of Bonnie-Ann Burnett
Introduction
Bonnie-Ann Burnett is a notable inventor based in Malvern, PA (US). He has made significant contributions to the field of functional genomics, particularly through his innovative patent. His work has implications for understanding post-transcriptional regulatory elements in mRNA.
Latest Patents
Bonnie-Ann Burnett holds a patent for a "Functional genomic screen for post-transcriptional 5′ and 3′ regulatory elements." This invention features cDNA libraries that consist essentially of cDNA sequences corresponding to different mRNA untranslated region (UTR) sequences, separate from adjacent mRNA coding sequences. The patent also includes methods for generating these libraries and for identifying a regulatory UTR sequence.
Career Highlights
Burnett's career is marked by his role at Message Pharmaceuticals, Inc., where he has been able to apply his expertise in genomics. His innovative approach has contributed to advancements in the understanding of gene regulation.
Collaborations
He has collaborated with notable colleagues such as Tony Giordano and Gordon Powers, enhancing the research environment and fostering innovation within his team.
Conclusion
Bonnie-Ann Burnett's contributions to functional genomics through his patent and work at Message Pharmaceuticals, Inc. highlight his role as a significant inventor in the field. His innovative research continues to pave the way for advancements in understanding gene regulation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile